Skip to main content
Premium Trial:

Request an Annual Quote

NuGen Technologies Raises $7.8M in VC Financing; Mike Hunkapiller Joins Board

NEW YORK, March 21 (GenomeWeb News) - NuGen Technologies said today that it has raised $7.8 million in private-equity funding.


The company will use the money to accelerate its technology development and expand global distribution for its RNA amplification and detection systems for gene expression research, NuGen said.


Alloy Ventures led the financing round, and existing NuGen investors Sutter Hill Ventures, Radius Ventures, and The Band of Angels also participated.


NuGen also said that Michael Hunkapiller, former president and general manager of Applied Biosystems, Celera founder, and Applera senior vice president, has joined the company's board of directors.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.